UNIPHARMA ApS: Financial statements 2013
CVR: 78881917
Source: annual report 2013, Danish Business Authority
01/01/2013 – 31/12/2013
UNIPHARMA ApS (CVR 78881917) has filed annual accounts for 2013. In 2013, the company reported a gross profit of DKK -6,187 and a net result of DKK -6,187 compared with DKK -5,125 the year before. Equity in the 2013 report amounted to DKK 105,126. The solvency ratio was 58.2%.
- Gross Profit
- DKK -6,187
- Profit/Loss
- DKK -6,187
- Equity
- DKK 105,126
- Total Assets
- DKK 180,490
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2013 | - | -6 t. | -6 t. | 105 t. | - |
| 2012 | - | -5 t. | -5 t. | 111 t. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2013
UNIPHARMA ApS has published its annual report for 2012. Gross profit came to DKK -5,125, and the net result was DKK -5,125.
About UNIPHARMA ApS
UNIPHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 1985. The company is under bankruptcy. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The company is owned by Ebba Dorrit Reumert. According to the 2023 annual report, the company had an average of 0 employees. In 2024, the company reported a gross profit of DKK 0 and a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2024 report amounted to DKK -124,033.